12 Month Price Forecast For DLHC
Distance to DLHC Price Forecasts
DLHC Price Momentum
๐ค Considering DLH Holdings (DLHC)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 10, 2025 3:47 PM UTC
DLHC Analyst Ratings & Price Targets
Based on our analysis of 1 Wall Street analysts, DLHC has a consensus that is bullish. The median price target is $15.00, with forecasts ranging from $15.00 to $15.00. Currently, there are 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With DLHC currently trading at $6.35, the median price forecast suggests a 136.2% upside. The most optimistic forecast comes from at , projecting a 136.2% upside, while at provides the most conservative target, suggesting a 136.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DLHC Analyst Consensus
DLHC Price Target Range
Latest DLHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DLHC.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Dec 8, 2020 | Canaccord Genuity | Buy | Maintains | $13.00 | |
Feb 23, 2017 | Noble Capital Markets | Buy | Initiates | $0.00 | |
Feb 23, 2017 | Noble Financial | Buy | Initiates | $0.00 |
Stocks Similar to DLH Holdings Corp
The following stocks are similar to DLH Holdings based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
DLH Holdings Corp (DLHC) Financial Data
DLH Holdings Corp has a market capitalization of $91.35M with a P/E ratio of 14.4x. The company generates $401.04M in trailing twelve-month revenue with a 0.6% profit margin.
Revenue growth is -1.5% quarter-over-quarter, while maintaining an operating margin of +5.7% and return on equity of +2.3%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

DLH Holdings Corp (DLHC) Company Overview
About DLH Holdings Corp
Provides technology-enabled business process outsourcing services.
The company generates revenue by offering a range of technology-enabled services including business process outsourcing, program management, and public health research. It serves various federal agencies like the NIH and the Department of Veterans Affairs, providing solutions such as data analytics, cybersecurity, and clinical trials research.
Founded in 1969 and headquartered in Atlanta, Georgia, DLH Holdings Corp. has expanded its offerings to include digital transformation services and system engineering solutions. The company formerly operated as TeamStaff, Inc. and rebranded in 2012, emphasizing its focus on technology and analytics in public health and defense sectors.
Company Information
Sector
Industrials
Industry
Specialty Business Services
Employees
3,200
CEO
Mr. Zachary C. Parker
Country
United States
IPO Year
1995
Website
www.dlhcorp.comDLH Holdings Corp (DLHC) Latest News & Analysis
DLH Holdings Corp. will host its Q1 2025 Earnings Conference Call on February 6, 2025, at 10:00 AM ET, featuring key executives including the CEO and CFO.
The earnings conference call indicates DLH Holdings' financial performance and future outlook, which can influence stock price and investor sentiment.
The company is addressing challenges in its transformation, reporting recent successes and an expanding bid pipeline, which may enhance its outlook for organic growth.
The company's transformation signals potential for improved performance, while a growing bid pipeline indicates increased revenue opportunities, enhancing overall growth prospects for investors.
DLH Holdings Corp. (NASDAQ: DLHC) will release Q1 fiscal 2025 results on February 5, 2025, after market close, and host a conference call on February 6 at 10:00 a.m. ET.
Upcoming financial results and management insights can impact DLH Holdingsโ stock price, affecting investor sentiment and potential market performance.
DLH Awarded OASIS+ GWAC ID/IQ Contract Vehicle
1 month agoDLH Holdings Corp. has secured a GWAC ID/IQ contract for professional services through the OASIS+ program, benefitting various federal agencies, including the Department of Defense.
DLH Holdings' GWAC ID/IQ contract enhances revenue potential and market position, signaling growth opportunities within federal contracts, which can positively impact stock performance.
Foot Locker, CVS Health, and Charles River Laboratories are identified as stocks that have been significantly affected but are poised for potential recovery.
Recovery potential in Foot Locker, CVS Health, and Charles River Laboratories signals possible buying opportunities and improved market sentiment, influencing portfolio strategies.
DLH Holdings Corporation (NASDAQ:DLHC) will host its Q4 2024 Earnings Conference Call on December 5, 2024, at 10:00 AM ET. Key executives will present during the call.
Earnings calls provide insights into a company's financial health and future outlook, influencing stock prices and investment decisions. The participation of notable analysts may signal market interest.
Frequently Asked Questions About DLHC Stock
What is DLH Holdings Corp's (DLHC) stock forecast for 2025?
Based on our analysis of 1 Wall Street analysts, DLH Holdings Corp (DLHC) has a median price target of $15.00. The highest price target is $15.00 and the lowest is $15.00.
Is DLHC stock a good investment in 2025?
According to current analyst ratings, DLHC has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.35. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for DLHC stock?
Wall Street analysts predict DLHC stock could reach $15.00 in the next 12 months. This represents a 136.2% increase from the current price of $6.35. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is DLH Holdings Corp's business model?
The company generates revenue by offering a range of technology-enabled services including business process outsourcing, program management, and public health research. It serves various federal agencies like the NIH and the Department of Veterans Affairs, providing solutions such as data analytics, cybersecurity, and clinical trials research.
What is the highest forecasted price for DLHC DLH Holdings Corp?
The highest price target for DLHC is $15.00 from at , which represents a 136.2% increase from the current price of $6.35.
What is the lowest forecasted price for DLHC DLH Holdings Corp?
The lowest price target for DLHC is $15.00 from at , which represents a 136.2% increase from the current price of $6.35.
What is the overall DLHC consensus from analysts for DLH Holdings Corp?
The overall analyst consensus for DLHC is bullish. Out of 1 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $15.00.
How accurate are DLHC stock price projections?
Stock price projections, including those for DLH Holdings Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.